These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 4976352)
21. Optimal intravesical dosage of thio-tepa in the prophylaxis of recurrent bladder papillomatosis. Oravisto KJ Scand J Urol Nephrol; 1972; 6(1):26-8. PubMed ID: 4626940 [No Abstract] [Full Text] [Related]
22. A trial of prophylactic thiotepa or mitomycin C intravesical therapy in patients with recurrent or multiple superficial bladder cancers. Flanigan RC; Ellison MF; Butler KM; Gomella LG; McRoberts JW J Urol; 1986 Jul; 136(1):35-7. PubMed ID: 3086575 [TBL] [Abstract][Full Text] [Related]
23. Intravesical thio-tepa in the immediate postoperative period in patients with recurrent transitional cell carcinoma of the bladder. Gavrell GJ; Lewis RW; Meehan WL; Leblanc GA J Urol; 1978 Oct; 120(4):410-1. PubMed ID: 100615 [TBL] [Abstract][Full Text] [Related]
32. [Comparative study of thiotepa, adriamycin and cisplatin in the prophylaxis of recurrence of superficial bladder carcinoma in a group of 217 patients]. Llopis B; Gallego J; Boronat F; Moreno B; Mompó JA; Jiménez JF Actas Urol Esp; 1986; 10(4):225-30. PubMed ID: 3092589 [No Abstract] [Full Text] [Related]
33. Long-term intravesical thiotepa treatment in patients with superficial bladder tumors and vesicoureteral reflux. Nissenkorn I; Servadio C; Vilikowski E; Glanz I J Urol; 1985 Feb; 133(2):198-9. PubMed ID: 3918177 [TBL] [Abstract][Full Text] [Related]
34. [The recurrence after conservative therapy of bladder cancer. II: The intravesical instillation of anti-cancer drug for preventing recurrence (author's transl)]. Saito K; Fukushima S; Takahashi Y; Takai S Nihon Hinyokika Gakkai Zasshi; 1980 May; 71(5):449-57. PubMed ID: 6774151 [No Abstract] [Full Text] [Related]
35. [Superficial bladder cancer: prophylaxis of recurrence and progression]. Miyanaga N; Akaza H; Koiso K Gan To Kagaku Ryoho; 1991 Nov; 18(14):2369-74. PubMed ID: 1719939 [TBL] [Abstract][Full Text] [Related]
36. Adriamycin instillations as recurrence prophylaxis in superficial urinary bladder cancer. Jauhiainen K; Alfthan O Ann Chir Gynaecol; 1984; 73(4):206-10. PubMed ID: 6508201 [TBL] [Abstract][Full Text] [Related]
37. [Chemoprophylaxis of superficial tumors of the bladder with thiotepa: long-term results]. Durán R; Reina GR; Hontoria JM; Merino C; Olivier C; Carballido J Actas Urol Esp; 1989; 13(1):19-23. PubMed ID: 2496583 [TBL] [Abstract][Full Text] [Related]
38. The use of intravesical thio-tepa in the management of non-invasive carcinoma of the bladder. Koontz WW; Prout GR; Smith W; Frable WJ; Minnis JE J Urol; 1981 Mar; 125(3):307-12. PubMed ID: 6782251 [No Abstract] [Full Text] [Related]
39. Use of mitomycin as prophylaxis following endoscopic resection of superficial bladder cancer. Huland H; Otto U Urology; 1985 Oct; 26(4 Suppl):32-5. PubMed ID: 4049627 [TBL] [Abstract][Full Text] [Related]
40. Hematologic effects of intravesicular thiotepa therapy for bladder carcinoma. Hollister D; Coleman M JAMA; 1980 Nov; 244(18):2065-7. PubMed ID: 6776297 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]